Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Ketogenic Inhibition of the Incretin GLP-1

NCT05154461 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05154461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05154461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Ketogenic Inhibition of the Incretin GLP-1
Lead sponsor
Göteborg University
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2021
Completion date
September 1, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult volunteers